FDA Investigator Mark E Chan
Mark E Chan has inspections in 15 countries as of 18 Oct 2023. Mark E Chan has collaborated with a combined 3451 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
207
Last Inspection Date:
18 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Denmark,
United States of America,
Japan,
Sweden,
Taiwan,
China,
Belgium,
Malaysia,
Netherlands,
Switzerland,
Singapore,
United Kingdom of Great Britain and Northern Ireland,
Germany,
Ireland
Co-Investigator(s):
A Williams,
Adam S Freeman,
Akbar J Zaidi,
Alexandria L Capuano,
Alla Dubrovsky,
Althea A Williams,
Amanda S Zorn,
Amogh Pathi,
Amy M Cramer,
Andersoneric,
Andrea P Scott,
Angel K Sandhu,
Angelica G Aziz,
Arduino Frankovic,
Arthur S Williams, Jr,
Ashar P Parikh,
Ashleigh P Wodushek,
Ashley A Mutawakkil,
Barbara A Crowl,
Barbara J Moynier,
Beverly A Gallauresi,
Brittany D Mccracken,
Bryan A Galvez,
Bryan J Love,
Carl Lee,
Carol A Llewellyn,
Caryn M Mcnab,
Catherine J Laufmann,
CDR Rochelle B Young, RPh, MSA,
CDR Sean T Creighton,
Christine I Shaw,
Christine M Parmentier,
Christopher B May,
Christopher W Buser,
Cindy W Lewis,
Creighton T Tuzon,
Cristina E Ortega,
Cristina O Dar,
Cynthia L Gorveatt,
Daniel C Geffin,
Daniel J Lahar,
Daniel J Roberts,
Darren S Brown,
David G Eng,
David H Smith,
David M Wilkinson,
David P Vanhouten,
Deborah A Nebenzahl,
Denise D Dion,
Diane Cvan Leeuwen,
Dianiris C Ayala,
Donna Ltartaglino Besone,
Dr. Xingxiang Li,
Edna J Hidalgo,
Elizabeth A Dakan,
Ellen J Tave,
Emil P Wang, JD,
Emma R Schaefer,
Eric J Heinze,
Eric M Padgett,
Eric W Anderson,
Felix J Marrero,
Francis J Eng,
Frank J Marciniak,
Gary L Taharek,
Gary L Zaharek,
Gene D Arcy,
George R Richards,
Gerald N Mcgirl, DDS,
Gulshan R Anand,
Harjap K Atwal,
Harperd,
Humberto Z Gomez,
Huy T Pham,
Jacqueline M Cleary,
Jacqueline S Warner,
James A Beaulieu,
James A Lane,
James C Lee, PharmD,
James D Hildreth,
James M Odonnell,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jeffrey S Buckser,
Jeffrey W Shrifter, DPM,
Jesse A Vazquez,
Joan T Briones,
Joanne Hosting,
Jocelyn T Ramos,
John A Gonzalez,
John A Liu,
John A Sciacchitano,
John F Murray, Jr,
Jolanna A Norton,
Jolene S Hedgecock,
Jonathan R Campos,
Joseph A Seitz,
Juan A Morales,
Jude C Dikes,
Kaarin M Slotte,
Karen A Coleman,
Karen D Phung,
Karl D Hezel,
Katlin N Stubbs,
Kavita K Lalwani,
Kenya Destin,
Keren Arkin,
Kevin P Foley,
Kimberly L Anderson,
Kimberly L Pruszko,
Kimberly Lewandowski Walker,
Kinh Q Mac,
Kirtida Patel,
Kristin M Abaonza,
Kwong P Lee,
L Gnnmassimia Massimilla, PharmD,
Lance A Finnical,
Lance M De Souza, MBA,
Larkin R Buckalew,
Lauren E Skokan,
Laverne Puckett,
Lawton W Lum,
LCDR Jennifer H Rhyu,
Lee,
Leo J Lagrotte,
Leonard H Lavi,
Linda Linh T Nguyen,
Linda S Shook,
Linda Thai,
Lori A Carr,
Lori J Silverstein,
Lorraine N Dixon,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Lydia S Chan,
Lynda L Perry, PhD,
Macropolk,
Maida Henesian (NMI),
Marie K Kinkade,
Mark E Chang,
Mark F Chan,
Mary R Hole,
Maryam Tabatabaie,
Matthew A Walburger,
Matthew D Schnittker,
Matthew M Vernon,
Melanie W Pishnery,
Michelle J Glembin,
Michelle L Tripp,
Minerva Rogers,
Norman Wong,
Patricia A Mcilroy,
Paul M Kawamoto,
Perry H Gambrell,
Peter E Baker,
Phillip M Pontikos,
Quynh H Strandberg,
Randall F Albright,
Randall J Plunkett,
Ravi S Harapanhalli,
Raymond T Oji,
Rebecca T Davis,
Reginald Walker,
Richard L Bartlett,
Richard L Rutherford,
Robert D Tollefsen,
Roberta K Smith,
Roger D Gawne,
Ronald P Boyce,
Roy Baby,
Sandra S Saniga,
Scott K Zika,
Seema S Singh,
Sergio Chavez (NMI),
Sherri J Jackson,
Stanley B Eugene, BS, BME,
State Agency,
Stephen C Smith,
Stephen D Eich,
Steve P Yost,
Steven R Ziser,
Suzanne M Healy,
Tamara S Rosbury,
Terri E Gibson,
Thai T Duong,
Thea C Grome,
Timothy C Grome,
Uduak M Inokon,
Vibhakar J Shah, PhD,
Vickie L Anderson,
Victor Spanioli,
Vivian Garcia,
Walden H Lee,
William D Tingley,
William V Millar,
Xiaojun Yan,
Yong Hu
Mark E Chan's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more